Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review

by Cristina Lussiana
Health Policy Plan. (2016) 31 (7): 928-939. – First published online: April 9, 2015

12 pp. 920 kB

Overall private sector subsidy programmes were effective in increasing availability of artemisinin-based combination therapies (ACTs) in the private sector and lowering average prices of ACTs in many malaria endemic countries. In order to link malaria treatment with a positive diagnosis for malaria, a subsidy of rapid diagnostic tests (RDTs) in the private sector has been advocated and recommended by governments and international donors. In order to improve the cost-effectiveness of a subsidy of RDTs, we should build on the lessons we learned from almost 10 years of private sector subsidy programmes of ACTs in the private sector of malaria-endemic countries.

(Visited 15 times, 1 visits today)
This entry was posted in Essential Medicines, General, Malaria. Bookmark the permalink.